Drug Type Small molecule drug |
Synonyms- |
Target |
Action degraders |
Mechanism IRAK4 degraders(Interleukin-1 receptor-associated kinase 4 degraders) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cardiovascular Diseases | Discovery | - | 13 Feb 2025 | |
| Cardiovascular Diseases | Discovery | - | 13 Feb 2025 | |
| Endometriosis | Discovery | - | 13 Feb 2025 | |
| Endometriosis | Discovery | - | 13 Feb 2025 | |
| Hepatitis | Discovery | - | 13 Feb 2025 | |
| Hepatitis | Discovery | - | 13 Feb 2025 | |
| Immune System Diseases | Discovery | - | 13 Feb 2025 | |
| Immune System Diseases | Discovery | - | 13 Feb 2025 | |
| Infectious Diseases | Discovery | - | 13 Feb 2025 | |
| Infectious Diseases | Discovery | - | 13 Feb 2025 |





